Bharat Biotech completes Covaxin Phase 2-3 clinical trials for children2 min read . Updated: 21 Sep 2021, 02:39 PM IST
- Ella also said the Phase 2 trials of the company's intranasal vaccine against coronavirus is expected to be over by next month
Hyderabad-based Bharat Biotech has completed the Phase 2 and 3 clinical trials of coronavirus vaccine, Covaxin for use in the age group of 2 to 18 years. The Hyderabad-based vaccine maker is expected to submit the data by next week to the DCGI.
Login to enjoy exclusive benefits!
- Unlocked premium articles
- Personalized news
- Market Watchlist
- Insightful Newsletters & more